Vion Pharmaceuticals Reports 2009 Second Quarter And Six-Mon... (looking forward to presenting our data t...)

Vion Pharmaceuticals Reports 2009 Second Quarter And Six-Month Results

Date:8/11/2009

looking forward to presenting our data to the Committee in support of Onrigin for its use as a new therapeutic agent for elderly poor-risk AML patients."

The Company reported ending the quarter with $26.1 million in cash and cash equivalents. Based on its current operating plan, management estimates that its existing cash and cash equivalents will be sufficient to fund operations through the second quarter of 2010. The Company's current operating plan assumes that Onrigin will be approved by the FDA in the fourth quarter of 2009 and has limited funds available for commercialization. If Onrigin is approved, the Company will either have to partner with another pharmaceutical company or raise additional capital for the commercialization of Onrigin.

Conference Call

The Company will hold a conference call at 8:30 a.m. Eastern Time on August 13, 2009 to discuss its operations and financial results.

To participate in the conference call, please dial (800) 901-5241 in the U.S. ((617) 786-2963 for international callers) at least 15 minutes before the start of the call. When prompted for a pass code, please enter 60356125.

An audio webcast of the call will be accessible at www.vionpharm.com. Those who wish to listen to the conference call on the Web should visit the Investor Relations section of the Company's website at least 15 minutes prior to the event broadcast, and follow the instructions provided to assure that the necessary audio applications are downloaded and installed. These programs can be obtained at no charge to the user.

A replay of the call will be available two hours after the completion of the call at

(888) 286-8010 in the U.S., ((617) 801-6888 for international callers), pass code 78450067. The replay will be available through August 27, 20009.

'/>"/>

SOURCE Vion Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6
Related medicine news :

1. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
2. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
3. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
4. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
5. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
6. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
8. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
9. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
10. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
11. Class Settlement Could Result in Considerable Savings for Certain Consumers of Prescription Pharmaceuticals

Post Your Comments:

(Date:9/2/2010)... Scientists have built a clearer picture of how lengthy strands ... in a discovery could help explain how cell renewal can ... play a key role in compacting DNA a crucial ... to fit inside cells as they split into two. , ... when this packaging process fails and cells divide abnormally ...

(Date:9/2/2010)... Amsterdam, 2 September, 2010 - Elsevier announced today ... the European Menopause and Andropause Society (EMAS) in ... on common management problems in the post-reproductive health ... of the menopause in the context of obesity, ... statement has summary recommendations as a quick aid ...

(Date:9/2/2010)... survey of emergency medical services (EMS) agencies from across ... safety cultureproviding a tool that might point to potential ... of Pittsburgh School of Medicine. , The ... of Prehospital Emergency Care and now available ... the U.S. and Canada. Researchers adapted a survey used ...

(Date:9/2/2010)... that fate and chance control their lives are ... faced with death they are likely to abandon ... University undergraduate research project. , The project, led ... graduate in psychology, Olathe, focuses on personality traits ... Doreen Shanteau Undergraduate Research Fellowship in 2009 to ...

(Date:9/2/2010)... to respect and support patients who use cannabis for ... follow professional guidance at all times, according to a ... Journal of Clinical Nursing . , Dr ... 50 published papers, together with professional and Government guidance ... 2009. , They point out that the fact that ...

Breaking Medicine News(10 mins):Health News:Scientists unwrap DNA packaging to gain insight into cells 2 Health News:EMAS publishes position statements about the post-reproductive health of women 2 Health News:Safety cultures in EMS agencies vary widely, Pitt study finds 2 Health News:K-State research project offers insight into superstitious behavior 2 Health News:K-State research project offers insight into superstitious behavior 3 Health News:Medicinal cannabis review highlights dilemmas facing health care professionals 2 Health News:Medicinal cannabis review highlights dilemmas facing health care professionals 3

[1] Scientists unwrap DNA packaging to gain insight into cells [1] EMAS publishes position statements about the post-reproductive health of women [0] Safety cultures in EMS agencies vary widely, Pitt study finds [0] K-State research project offers insight into superstitious behavior [1] Medicinal cannabis review highlights dilemmas facing health care professionals

... Calif., Nov. 1 Kaiser Permanente Chairman and,Chief ... executives,who received the CEO Diversity Leadership Award from ... Inclusion Leadership Summit &,Gala on November 1, 2007. ... in the health care sector. Halvorson was ...

... to Present Data and Discuss Emerging Advances in Basic ... Neuroscience 2007 Satellite Symposium, ABBOTT PARK, Ill., Nov. ... that nerve cells use to,communicate to one another, in ... memory and attention. Based on a growing body of,scientific ...

... National patient satisfaction survey ranks Sutter Fairfield Surgical Center ... percent of region,s ambulatory surgery centers, FAIRFIELD, Calif., ... Sutter Regional Medical Foundation, ranks in the top,one percent ... Western,states. That,s according to the results of a recent ...

... year, - Fourth-quarter earnings per share from continuing operations increased ... 15% to 98 cents ... specified items, increased ... from continuing operations, excluding specified items, to increase ...

... researchers at Jefferson Medical College have for the first ... the human spine, suggesting that such cells might someday ... lower back and neck pain. , Reporting November ... by Makarand Risbud, Ph.D., and Irving Shapiro, Ph.D., at ...

... a,million fewer Pennsylvanians are receiving health insurance through their,employer ... to a report,released jointly today by the Economic Policy ... Center in Harrisburg. That decrease was the largest ... 200,000 of those newly non-covered residents were children, the,report ...

Kaiser Permanente CEO Receives Diversity Leadership Award Abbott Researchers Target Neuronal Nicotinic Receptors for Treatment of Pain and Cognition Sutter Fairfield Surgical Center Ranks Best in Region BD Announces Results for Fourth Fiscal Quarter and Full Year Jefferson researchers find stem cells in degenerating spinal discs, potential for repair PA Residents Losing Employer Coverage at Rate Second Only to CA

(Date:9/2/2010)... HART Health, a national manufacturer and distributor of commercial ... of Synergy Logistics, a Seattle-based first aid supply company. ... system. Synergy Logistics, Inc. had been providing ... to mid-sized Seattle businesses since the early 1990,s and ... fold Synergy customers into its existing Seattle van service. ...

(Date:9/2/2010)... Sept. 2 Transdel Pharmaceuticals, Inc. ... a specialty pharmaceutical company focused on developing ... delivery platform, announced today the final data ... Ketotransdel® (TDLP-110) at the 13th World Congress ... Company,s lead pain product candidate, utilizes its ...

(Date:9/2/2010)... -- According to Millennium Research Group (MRG), the ... Japanese plate and screw market will be driven ... market to over $170 million by 2014. ... plating systems, such as Acumed,s Acu-Loc ... in order to manage complex, periarticular fractures. This ...

[0] First Aid Supplier HART Health Acquires Competitor and Continues Expansion [0] Transdel Pharmaceuticals Presents Phase 3 Study Data on Ketotransdel® at World Pain Congress in Montreal, Canada [0] Surgeons Drive Plate and Screw Market to Over $170 Million in Japan by 2014

... 7, 2007 - Gemin X,announced today that ... of,the journal Blood demonstrated that its lead ... multiple myeloma tumor cells as a single-agent, ... combination therapy.,GX15-070 is a small molecule specifically ...

... data underlines M6G's,benefit compared to morphine in ... 7th March 2007 - CeNeS Pharmaceuticals plc,(AIM: ... additional data from the pivotal Phase III ... patients with,post-operative pain. The preliminary data released ...

Other Medicine Technology:Gemin X Announces Publication of Preclinical Data of GX15-070 in,Multiple Myeloma in Blood 2 CeNeS Pharmaceuticals plc: Update on Successful Phase III results,announced on Lead Product M6G 2 CeNeS Pharmaceuticals plc: Update on Successful Phase III results,announced on Lead Product M6G 3 CeNeS Pharmaceuticals plc: Update on Successful Phase III results,announced on Lead Product M6G 4 CeNeS Pharmaceuticals plc: Update on Successful Phase III results,announced on Lead Product M6G 5 CeNeS Pharmaceuticals plc: Update on Successful Phase III results,announced on Lead Product M6G 6 CeNeS Pharmaceuticals plc: Update on Successful Phase III results,announced on Lead Product M6G 7

Gemin X Announces Publication of Preclinical Data of GX15-070 in,Multiple Myeloma in Blood CeNeS Pharmaceuticals plc: Update on Successful Phase III results,announced on Lead Product M6G

Inquire...

Perfect for physicians who prefer a Heavier and Longer tubing, permitting them maximum access around the OR table. 12 feet in length Sizes availabe to fit any vacuum canisters...

Inquire...

... a compact system featuring,easy setup and flow ... allowing the use of less,expensive disposable tubing ... office or hospital use, the,PSI-TEC III Infiltrator ... - 5" (w) X 8" (l) X ...

Medicine Products:

Super Flex Suction Tubing HK Heavy, Extra Long Liposuction Aspiration Tubing Liposuction Cannulas PSI-TEC III Tumescent Infiltrator System

Vion Pharmaceuticals Reports 2009 Second Quarter And Six-Mon...(looking forward to presenting our data t...),Health